Showing results (131-140 of 785) with videos related to

Sort By:
Pageof 79
The Lancet. HIV|October 22, 2018
Population-level effectiveness of rapid, targeted, high-coverage roll-out of HIV pre-exposure prophylaxis in men who have sex with men: the EPIC-NSW prospective cohort studyAndrew E Grulich, Rebecca Guy, Janaki Amin, et al.
The Lancet. HIV|October 6, 2019
Adolescent HIV treatment in South Africa's national HIV programme: a retrospective cohort studyMhairi Maskew, Jacob Bor, William MacLeod, et al.
The Lancet. HIV|September 28, 2019
Pre-exposure prophylaxis 2.0: new drugs and technologies in the pipelineLara Esteves Coelho, Thiago Silva Torres, Valdiléa Gonçalves Veloso, et al.
The Lancet. HIV|October 4, 2019
Bone mineral density in virologically suppressed people aged 60 years or older with HIV-1 switching from a regimen containing tenofovir disoproxil fumarate to an elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide single-tablet regimen: a multicentre, open-label, phase 3b, randomised trialFranco Maggiolo, Giuliano Rizzardini, François Raffi, et al.
The Lancet. HIV|November 20, 2016
Interventions to improve adherence to antiretroviral therapy: a systematic review and network meta-analysisSteve Kanters, Jay J H Park, Keith Chan, et al.
The Lancet. HIV|March 4, 2017
Geographical disparities in HIV prevalence and care among men who have sex with men in Malawi: results from a multisite cross-sectional surveyAndrea L Wirtz, Gift Trapence, Dunker Kamba, et al.
The Lancet. HIV|March 20, 2019
Recommendations for analytical antiretroviral treatment interruptions in HIV research trials-report of a consensus meetingBoris Julg, Lynda Dee, Jintanat Ananworanich, et al.
The Lancet. HIV|April 23, 2017
Sources of racial disparities in HIV prevalence in men who have sex with men in Atlanta, GA, USA: a modelling studySteven M Goodreau, Eli S Rosenberg, Samuel M Jenness, et al.
The Lancet. HIV|April 16, 2017
Comparison of dynamic monitoring strategies based on CD4 cell counts in virally suppressed, HIV-positive individuals on combination antiretroviral therapy in high-income countries: a prospective, observational studyEllen C Caniglia, Lauren E Cain, Caroline A Sabin, et al.
The Lancet. HIV|April 19, 2017
Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trialJudith A Aberg, Craig A Sponseller, Douglas J Ward, et al.
Pageof 79